phase readout
saveNCT05164094: A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
ACTIVE_NOT_RECRUITINGupdated 10d ago
community read0 votes
Sponsor: ModernaTX, Inc.. Phase: PHASE1. Conditions: Epstein-Barr Virus Infection
view source ↗
comments(0)
5-min edit window · permanent after that